Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

220 results about "Placenta" patented technology

The placenta is a temporary organ that connects the developing fetus via the umbilical cord to the uterine wall to allow nutrient uptake, thermo-regulation, waste elimination, and gas exchange via the mother's blood supply; to fight against internal infection; and to produce hormones which support pregnancy. Placentas are a defining characteristic of placental mammals, but are also found in marsupials and some non-mammals with varying levels of development.

Preparation method of placenta active factor as well as product and application of placenta active factor

The invention relates to a preparation method of a placenta active factor as well as a product and application of the placenta active factor, and the preparation method comprises the following steps: soaking and rinsing a full-month normal delivery placenta, and homogenizing to obtain homogenate; repeatedly freezing and thawing the homogenate to collect a thaw solution, centrifuging the thaw solution, taking a supernatant, mixing the supernatant with a compound enzyme, and carrying out ultrasonic enzymolysis extraction to obtain an enzymolysis product; and centrifuging the enzymolysis product, taking the supernatant, and carrying out membrane filtration to obtain the placenta active factor. The compound enzyme comprises a combination of animal protein hydrolysis compound enzyme, alkaline protease, neutral protease and papain. The placenta tissue is extracted through cooperation of the specific compound enzyme and ultrasonic waves, the placenta tissue and the specific compound enzyme have a synergistic effect, the extraction efficiency can be further improved, the content of active ingredients in the extract is high, the biological activity is high, and the obvious anti-oxidation and anti-aging effects are achieved.
Owner:GUANGZHOU RUIBOYIN HEALTH TECH CO LTD

Immunoregulation drug delivery system for specifically targeting focus MDSC cells and preparation method and application of immunoregulation drug delivery system

The invention discloses an immunoregulation drug delivery system for specifically targeting focus MDSC cells as well as a preparation method and application of the immunoregulation drug delivery system. The delivery system is of a double-layer vesicle structure, an inner-layer vesicle is a polymer vesicle of an antibody targeting MDSC cell surface marker, the outer wall of the inner-layer vesicle is positively charged and loads an immunoregulation therapeutic gene, and a therapeutic drug is loaded in the inner-layer vesicle; the outer-layer vesicle is an enzyme substrate polypeptide-PEG (Polyethylene Glycol) modified liposomal vesicle which can be disintegrated in a targeted manner under the action of a placenta interstitial fluid high-expression enzyme. The delivery system provided by the invention can realize regulation and control of MDSC in the placenta and regulation and control of immunity in the placenta, avoids influence on functions of other cells in the placenta, can effectively reduce medicine leakage through maternal and fetal barriers, and reduces toxicity to fetuses and maternal bodies.
Owner:THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV

Acellular fish skin matrix biological scaffold as well as preparation method and application thereof

The preparation method comprises the following steps: (1) fish skin pretreatment: (2) gas foaming treatment: weighing sodium borohydride with a certain molar concentration, dissolving the sodium borohydride in a phosphate buffer solution with a certain concentration, stirring until bubbles in the solution are obviously generated and most of solids are dissolved, and then, carrying out gas foaming treatment; putting the cleaned fish skin tissues in the step (2), and performing foaming treatment; (3) cleaning treatment; and (4) protection and storage. The gas foaming technology is innovatively adopted for decellularization treatment, the interface stripping effect between cells and a matrix is remarkably enhanced on the premise that the collagen three-dimensional structure and the scaffold morphology integrity are not damaged, and the method is suitable for the decellularization pretreatment process of soft tissue (such as fish skin and placenta) with a compact structure or cell-intensive type. The development of a biomedical material, especially a tissue engineering scaffold technology, is promoted, and the preparation method has a wide application prospect.
Owner:QINGDAO UNIV

Gene Idh1 conditional knockout mouse model and construction method and application of preeclampsia-induced heart injury animal model

The invention provides a construction method and application of a gene Idh1 conditional knockout mouse model and a preeclampsia heart injury animal model, and relates to the technical field of biology. According to the preeclampsia heart injury animal model, flox mice with conditional gene Idh1 knockout and mice with placental trophoblast specific expression Cre recombinase comate, PE-related phenotypes and typical symptoms of heart injury spontaneously appear in the double-positive pregnant mouse model, and the double-positive pregnant mouse model can be used for research of disease causes, diagnosis methods and drug research and development.
Owner:NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV

Classifier for early recognition and severity prediction of placenta implantable diseases and training system thereof

The invention discloses a classifier for early recognition and severity prediction of placenta implantable diseases and a training system thereof. The system performs normalization and discretization based on pregnant woman plasma free whole genome DNA promoter region coverage rate analysis, identifies the optimal target combination of 15 genes, including MAPK10, MIR3169, MIR12133 and the like, and has application potential in preparation of diagnostic kits. By applying a machine learning algorithm, the constructed classifier shows high sensitivity and specificity in early prediction of PAS and severity of PAS, the AUC (area under operation characteristic curve) of a receiver exceeds 0.85, early risk assessment of high-risk pregnant women is effectively realized, and heavy PAS pregnant women are identified to reduce crisis of obstetrics. The classifier provides a non-invasive prediction tool for clinic, and has remarkable clinical application value and medical significance.
Owner:CHANGZHOU MATERNAL & CHILD HEALTH CARE HOSPITAL

KASP molecular marker related to high temperature resistance character of patinopecten yessoensis and application of KASP molecular marker in genetic breeding

The invention belongs to the technical field of aquatic product breeding, and particularly relates to a KASP molecular marker related to high temperature resistance character of patinopecten yessoensis and application of the KASP molecular marker in genetic breeding. On the basis of genome re-sequencing of 200 patinopecten yessoensis, a PySNP587919 locus obviously associated with the patinopecten yessoensis high-temperature-resistant character is screened by combining a whole genome SNP genotype and whole genome association analysis of the patinopecten yessoensis high-temperature-resistant character, and after the reliability of the locus is verified through Sanger sequencing, the locus is developed into a KASP marker, and the KASP marker can be used for identifying the high-temperature-resistant character of the patinopecten yessoensis and identifying the high-temperature-resistant character of the patinopecten yessoensis. The screening method can be used for screening the high-temperature-resistant comb shells. Furthermore, the invention also establishes a method for screening the high-temperature-resistant patinopecten yessoensis, and the method is efficient and accurate. Therefore, the technical scheme provided by the invention is suitable for molecular marker-assisted breeding work, rapid and effective screening of parents can be realized by typing the PySNP587919 site, and the breeding efficiency is improved.
Owner:DALIAN OCEAN UNIV

Stem cell extraction process

The invention relates to the technical field of stem cell extraction, in particular to a stem cell extraction process, solves the problems that when stem cells in a placenta are extracted in the prior art, the temperature in the placenta treatment process is inconvenient to keep stable, and the placenta is inconvenient to fully crush and clean, and is used for extracting the placenta stem cells. The stem cell extraction process is realized through stem cell extraction equipment, the stem cell extraction equipment comprises a circulating cooling mechanism, a coarse crushing mechanism, a fine crushing mechanism and a digestion separation mechanism, the coarse crushing mechanism is mounted on the inner side of the upper end of the circulating cooling mechanism, the fine crushing mechanism is mounted at the bottom end of the coarse crushing mechanism, and the digestion separation mechanism is mounted at the bottom end of the fine crushing mechanism. A digestion and separation mechanism is mounted on one side of the fine crushing mechanism, and the circulating cooling mechanism comprises a supporting base. Through continuous cleaning and gas injection in the stem cell extraction process, the temperature stability of the stem cells can be effectively kept, and the placenta cleaning and crushing effects can be conveniently improved.
Owner:ZHONGSHU TECHNOLOGY (GANSU) CO LTD

Method for directly inducing organoid from IPS and application

ActiveCN119490950AImprove cryopreservation survival rateGood freezing survival rateArtificial cell constructsArtificially induced pluripotent cellsGerm layerDisease
The invention discloses a method for directly inducing generation of organoids from IPS and application, and belongs to the field of cell engineering. The invention provides a method for directly and rapidly generating a target organ based on human IPS, and the lung organ, the placenta organ and the blood vessel organ are obtained. According to the method, the organoid represented by three germ layers is induced, so that the method is suitable for constructing various organoid. Compared with the prior art, the method has the advantages that step-by-step induction is not needed, one-step construction is successful, the operation is simple, the construction time is greatly shortened, the process is repeatable, long-term stable culture and passage are realized under in-vitro conditions, and the freezing survival rate is high; the method has the advantages that the method is simple in operation, the cultured organoid is good in homogeneity, RNA-seq results show that high expression of the blood vessel related genes appears in the organoid, and the maximum length of the organoid can reach 400 micrometers, so that the culture method can spontaneously induce expression of part of the blood vessel related genes to support growth of the organoid. The invention provides an important tool for researching pathogenesis of diseases and subsequent drug development.
Owner:KUNMING UNIV OF SCI & TECH

Application of cow placenta peptide in preparation of product for protecting intestinal flora disorder caused by cyclophosphamide

The invention discloses application of a dairy cow placenta peptide as shown in a formula I in preparation of a product for protecting intestinal flora disorder caused by cyclophosphamide. The dairy cow placenta peptide is QPGLPGPAG (H-Gln-Pro-Gly-Leu-Pro-Gly-Pro-Ala-Gly-OH), the molecular formula of the dairy cow placenta peptide is C35H56N10O11, the molecular weight of the dairy cow placenta peptide is 792.89 Da, and the dairy cow placenta peptide can be used for preparing a product for protecting intestinal flora disorder caused by cyclophosphamide. # imgabs0 #
Owner:SICHUAN AGRI UNIV

Application of cow placenta polypeptide in preparation of medicine for protecting intestinal injury caused by cyclophosphamide

The invention discloses an application of cow placenta polypeptide in preparation of a medicine for protecting intestinal injury caused by cyclophosphamide, which comprises the following steps: cutting the placenta of a healthy Chinese Holstein cow in normal delivery into pieces, homogenizing by using a tissue homogenizer, adding papain, acting for 4.7 hours under the conditions that the pH value is 6.5 and the temperature is 55 DEG C, centrifuging after inactivating for 10 minutes in a boiling water bath, collecting the supernatant, and performing freeze-drying to obtain the cow placenta polypeptide. The dairy cow placenta polypeptide ANNGKQWAEVF (H-Ala-Asn-Asn-Gly-Lys-Gln-Trp-Ala-Glu-Val-Phe-OH) is screened through a virtual screening method and molecular docking after freeze drying, the affinity of the dairy cow placenta polypeptide ANNGKQWAEVF (H-Ala-Asn-Asn-Gly-Lys-Gln-Trp-Ala-Glu-Val-OH) and Keap1 is the strongest, the molecular formula of the dairy cow placenta polypeptide is C57H82N16O17, and the molecular weight of the dairy cow placenta polypeptide is 1263.38 Da. The dairy cow placenta polypeptide can improve the villus form of the Release of intestinal barrier related factors is regulated, and expression of intestinal barrier genes is up-regulated.
Owner:SICHUAN AGRI UNIV

A traditional Chinese medicine composition for preventing and treating knee osteoarthritis and its preparation method

ActiveCN120771211BAntipyreticAnalgesicsLycopus lucidusSalvia miltiorrhiza
This invention provides a traditional Chinese medicine composition for the prevention and treatment of knee arthritis. The active ingredients, by weight, include: 15-25 parts of Salvia miltiorrhiza, 8-15 parts of Ligusticum chuanxiong, 12-20 parts of Angelica sinensis, 7-15 parts of Lycopus lucidus, 15-30 parts of Poria cocos, 8-15 parts of Placenta hominis, 18-30 parts of Clematis chinensis, 15-25 parts of Spatholobus suberectus, 25-40 parts of Paeonia lactiflora, 12-20 parts of Rehmannia glutinosa, and 8-15 parts of Glycyrrhiza uralensis. Using Salvia miltiorrhiza, Ligusticum chuanxiong, Angelica sinensis, Lycopus lucidus, Poria cocos, Placenta hominis, Clematis chinensis, Spatholobus suberectus, Paeonia lactiflora, Rehmannia glutinosa, and Glycyrrhiza uralensis as raw materials, this invention follows the principle of "principal, assistant, adjuvant, and guide" in traditional Chinese medicine. The combined use of these herbs can tonify the liver and kidneys, promote blood circulation and remove blood stasis, and has a good therapeutic effect on knee arthritis caused by liver and kidney deficiency and qi stagnation and blood stasis.
Owner:HUNAN ACAD OF CHINESE MEDICINE

Preparation method of boiling antigen for vibrio parahaemolyticus serum agglutination

The invention discloses a preparation method of a boiling antigen for vibrio parahaemolyticus serum agglutination. The preparation method comprises the following steps: selecting common serotype vibrio parahaemolyticus in monitoring for resuscitation; scraping a ring of placenta by using 10 mu L of an inoculating loop, dissolving the placenta in 1 mL of normal saline to prepare a bacterial suspension, and preparing 3 tubes of bacterial suspensions from each strain; boiling the bacterial suspension in boiling water for 1 hour, 45 minutes and 30 minutes respectively; and after boiling, centrifuging at 10000 rpm for 10 minutes, discarding the supernate, and reserving the precipitate as a boiling antigen for serum agglutination. The result shows that the agglutination accuracy after boiling for 1 hour is 100%, and the agglutination degree is 2 + or above; and no significant difference exists between 45 minutes of boiling and 1 hour of boiling, and no significant difference exists between 30 minutes of boiling. Compared with a high-pressure method, the method has the advantages that the operation time is shortened by 2-3 hours, special equipment certificates are not needed, and the method is suitable for daily detection and food poisoning traceability.
Owner:BEIJING FENGTAI DISTRICT CENT FOR DISEASE CONTROL & PREVENTION

Placenta collecting and cleaning pretreatment device

In order to solve the problems that the placenta collecting, cleaning and preprocessing processes are complex in operation and prone to pollution, the placenta collecting, cleaning and preprocessing device comprises a box body and a box cover, and is characterized by further comprising a partition plate, at least two sets of bosses are arranged on the inner wall of the box body in the height direction, sieve holes are formed in the partition plate, and the partition plate is provided with a baffle. The diameter of the partition plate is smaller than the diameter of the inner wall of the box body and larger than the inner diameter of the boss, the outer edge of the partition plate is provided with a groove distributed corresponding to the boss in position, the boss is in clearance fit with the groove, the vertical position of the placenta is changed through the partition plate, and the placenta collecting, cleaning and processing functions are achieved. The problems that the operation of separating placenta collection, cleaning and treatment for multiple times of container conversion is tedious and pollution is easily caused by multiple placenta transfer are solved.
Owner:SHANDONG YIYUAN PLURIPOTENT STEM CELL BIOENGINEERING CO LTD

Application of immune costimulatory factor TNFSF9 / TNFRSF9 as marker in preparation of preeclampsia early prediction product

The invention provides an application of a pair of immune costimulatory factors TNFSF9 / TNFRSF9 as markers in preparation of a product for early prediction of preeclampsia, and the immune costimulatory factors comprise a tumor necrosis factor superfamily member 9 (TNFSF9) and a tumor necrosis factor receptor superfamily member 9 (TNFRSF9). The product is used for carrying out early warning on the preeclampsia occurrence risk 20 weeks before pregnancy. The product is used for detecting the immune costimulatory factor through at least one of serum, plasma, whole blood and placental tissue. The invention aims to improve the early prediction efficiency of preeclampsia by detecting the abnormal expression level of the pair of markers.
Owner:ZHUJIANG HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY

Tissue cleaning solutions and related methods

This disclosure generally relates to methods of preparing a graft for wound healing. In some embodiments, the methods comprise obtaining a donor placenta and isolating tissue comprising amnion and / or chorion from the donor placenta. In other embodiments, the methods comprise washing the isolated tissue with a cleansing solution. Other embodiments, still, are directed toward applying a current to the isolated tissue and / or cleansing solution to produce the graft for wound healing.
Owner:TIDES MEDICAL LLC

Equipment for extracting effective components of camel placentin

The utility model relates to the technical field of biology, and particularly discloses a camel placentin effective component extraction device which comprises a homogenate mechanism which comprises a liquid storage tank assembly, a stirring assembly installed on the liquid storage tank assembly, an interception assembly clamped and embedded in the liquid storage tank assembly in a sliding mode and an electric push rod used for driving the interception assembly to ascend and descend; the filtering mechanism comprises a filtering box assembly; the output end of the electric push rod is controlled to push the connecting plate to move upwards, the connecting plate drives the intercepting plate on the guide rod to move upwards, at the moment, the intercepting plate does not block the discharge port any more, camel placenta tissue homogenate in the liquid storage tank body flows into the filter tank body through the discharge port, and after being filtered by the microporous filter membrane, the camel placenta tissue homogenate flows into the filter tank body. Solid particles, impurities and cell debris in homogenate are intercepted above the microporous filter membrane, and liquid flows out of the bottom of the filter box body after passing through the microporous filter membrane for next centrifugal treatment, so that the separation purity is improved.
Owner:XINJIANG MOUNTAIN BIOTECHNOLOGY CO LTD

Vibratory placenta cleaning device

The utility model discloses a vibratable placenta cleaning device for a laboratory, which comprises a placenta cleaning device body, and the placenta cleaning device body is provided with a bottom plate, a top tray, a bottom tray, a vibration device and a liquid storage bottle; a supporting structure is arranged below the bottom plate, a working interface is arranged above the bottom plate, vibration devices are arranged on the left side and the right side of the working interface, each vibration device is composed of a spring, a rack, a half gear and a gear support, a semicircular cavity is formed in the middle of the working interface, a top tray and a bottom tray are arranged in the cavity, and a liquid drainage structure is arranged at the bottom of the top tray. The bottom tray is arranged below the top tray, the top tray and the bottom tray are consistent in shape, the diameter of the bottom tray is larger than that of the top tray, and the top tray can be placed on the bottom tray. According to the placenta cleaning device capable of vibrating for the laboratory, placenta can be fully cleaned conveniently, the contamination risk is reduced, and meanwhile productivity is liberated.
Owner:HEILONGJIANG HENGSHENG STEM CELL ENG +1

DNA methylation signatures of maternal blood leukocytes and placenta predict fetal growth restriction (FGR)

The present disclosure provides for a method of treating fetal growth restriction in a fetus comprising obtaining a blood sample from a pregnant subject; isolating cell-free fetal DNA from the blood sample; testing the cell-free fetal DNA for a first DNA methylation level of 0.5800 or less in a group of genes, wherein the group of genes comprises the genes of any one of Tables 19-21, wherein the first DNA methylation level is calculated via an average of all differentially methylated islands of cytosine and guanine dinucleotides separated by only one phosphate in the 5' to 3' direction (5'-C-phosphate-G-3') (CpGIs) in differentially methylated regions (DMRs); and when the first DNA methylation level is 0.5800 or less, selecting a treatment from the following: monitoring the fetus during pregnancy of the pregnant subject, tracking movements of the fetus, admitting the pregnant subject to a hospital prior to going into labor, inducing early delivery of the fetus, performing an emergency Cesarean section on the pregnant subject, administering corticosteroids to the pregnant subject, or administering corticosteroids to the fetus upon birth. Other related methods are disclosed herein.
Owner:UNIV OF SOUTH FLORIDA

Composition for treating hypothyroidism

The present invention discloses a composition for treating hypothyroidism. The formula includes: placenta, antler, Pseudostellaria baicalensis, Salvia miltiorrhiza, and Herba Lycopodii. The prescription of the present invention is demonstrated to have therapeutic effects on hypothyroidism from both traditional Chinese medicine and modern medicine perspectives: from the perspective of traditional Chinese medicine, the efficacy of the present invention in replenishing qi and blood, regulating yin and yang, tonifying kidney essence, filling the marrow sea, and unblocking meridians is unique in treating goiter. From the perspective of modern medicine: Panlushending Jiawei Decoction has the effects of promoting cell reproduction, differentiation, and repairing damaged cells, and is also anti-apoptotic. It also has the effects of promoting the regeneration of vascular endothelial cells, forming new blood vessels, increasing blood flow rate, increasing blood supply, and increasing the secretion and synthesis of thyroid hormones. It can also increase the level of free hormone reabsorption from the intestine and lower the concentration of antibodies.
Owner:AFFILIATED HOSPITAL OF YULIN HEALTH SCHOOL

Collagen reinforced tissue grafts

This invention is directed to a multi-layered tissue graft comprising a collagen layer and at least one separated and washed placental tissue component and / or umbilical cord component, wherein the collagen is human collagen substantially free of non-human antigens.
Owner:MIMEDX GROUP INC

Application of reagent for inhibiting expression of circular RNA hsacirc0001360 in preparation of medicine for treating preeclampsia

The invention belongs to the technical field of biology, and particularly relates to application of a reagent for inhibiting expression of circular RNA hsacirc0001360 in preparation of a medicine for treating preeclampsia, the medicine inhibits inflammation, by conducting CircRNAs sequencing and subsequent verification on placenta tissue, hsacirc0001360 is determined as a research object, the relation between hsacirc0001360 and PE is disclosed, and the action mechanism of ncRNAs in PE is perfected.
Owner:NINGXIA MEDICAL UNIV

Method for extracting biologically active substances from sheep placenta

The invention discloses a method for extracting bioactive substances from sheep placenta, and relates to the technical field of animal placenta extraction. The method uses immobilized lipase to enzymolyze the crushed fresh sheep placenta, then adds protease to continue enzymolysis, and after the enzyme is inactivated, the purified bioactive substances have a high yield; and the immobilized lipase prepared by the chitosan derivative modified by the thiazole group has good application stability; in addition, the present invention also uses S-benzyl-L-cysteine ​​methyl ester hydrochloride to undergo a substitution reaction with a polyamide nanofiltration membrane, and the obtained nanofiltration membrane is used in the purification process of the bioactive substance, which has a good decolorization effect.
Owner:INNER MONGOLIA NOBLE FAMILY HEALTH MANAGEMENT CO LTD

Construction method and application of enterovirus 71 type susceptible transgenic mouse model

The invention discloses a construction method and application of an enterovirus 71 type susceptible transgenic mouse model, and belongs to the technical field of biology. The method comprises the following steps: up-regulating or enhancing or improving the content or / and activity of placenta specific protein 8 in a receptor mouse to obtain a mouse overexpressing the placenta specific protein 8, hybridizing the mouse overexpressing the placenta specific protein 8 with a wild mouse to obtain an F1-generation heterozygote mouse, a homozygote mouse obtained after the F1-generation heterozygote mice are hybridized with each other is an enterovirus 71 type susceptible transgenic mouse model. The application has the advantages that not only is the susceptibility of mice to EV71 increased, but also a proper animal model is provided for exploring the important function of Plac8 in the EV71 infection process.
Owner:INST OF PLA FOR DISEASE CONTROL & PREVENTION

Application of clostridium praeparatum in preparation of medicine for treating early abortion

InactiveCN121422070AUnknown materialsSexual disorderBiotechnologyRecurrent miscarriage
The invention relates to the field of biological medicines, relates to a treatment technology for early abortion, and in particular relates to an application of Clostridium prausnitzii (Faecalibacterium prausnitzii) in preparation of a medicine for treating early abortion. An experiment of a Poly (I: C) induced early-stage abortion mouse model proves that the clostridium praeparatum can obviously reduce the embryo loss rate and improve placenta development through oral intragastric administration. The action mechanism is that maternal immune balance is regulated by increasing the proportion of regulatory T cells (Treg) and inhibiting excessive activation of an IL-17 signal channel. As human intestinal symbiotic bacteria, the clostridium praeparatum is high in safety and can be used for intervention of early abortion, especially recurrent abortion, and a new strategy is provided for clinic.
Owner:SHENGJING HOSPITAL OF CHINA MEDICAL UNIVERSITY

Nucleic acid aptamer specifically recognizing placenta-specific protein 1 and use thereof

This invention belongs to the field of biotechnology and discloses a nucleic acid aptamer that specifically recognizes placental-specific protein 1 and its uses. The nucleotide sequence of the nucleic acid aptamer includes any one of the sequences shown in SEQ ID No. 1-57. This invention employs X-aptamer screening technology, combined with high-throughput sequencing technology and bioinformatics analysis, to reduce the number of screening rounds and obtain candidate nucleic acid aptamers. Further analysis of their affinity and specificity yields a nucleic acid aptamer that specifically recognizes placental-specific protein 1. The nucleic acid aptamer of this invention has the characteristics of high affinity and specificity, good stability, convenient synthesis, and easy labeling of functional groups. It can be used for the detection or binding of placental-specific protein 1, the diagnosis of placental-specific protein 1-related diseases, and the preparation of products for prognosis.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

3-oxoLCA for reducing oxidative stress and inflammation in pregnant dams and their offspring

The present invention relates to the medical and food use of bile acid derivatives. Specifically, the present invention relates to the use of 3-oxoLCA in reducing oxidative stress and inflammation in pregnant mothers and their offspring. Specifically, the present invention relates to the use of 3-oxoLCA to reverse the effects of oxidative stress on pregnant mothers, in particular, to maintain fetal equal weight, significantly reduce placental and liver oxidative stress in pregnant mothers and the resulting inflammation or dysfunction of the placenta and liver, and to improve the intestinal flora imbalance of pregnant mothers. Further studies have found that 3-oxoLCA has long-term effects, in particular, can significantly reduce the effects of oxidative stress during pregnancy on oxidative stress and inflammation in the liver of offspring.
Owner:FEED RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES

A composition for resisting PRRSv and improving sow reproductive performance and its application

ActiveCN119524054BImprove reproductive performanceImprove physiological and biochemical indicatorsFood processingAntiviralsBiotechnologyLeonurus japonicus
The present application relates to the field of traditional Chinese medicinal materials, in particular to a composition for resisting PRRSv and improving the reproductive performance of sows and application thereof. The present application formulates a composition composed of 10 plant extracts (Angelica sinensis extract, Atractylodes macrocephala Koidz extract, Glycyrrhiza uralensis Fisch extract, Eucommia ulmoides Oliver extract, Eucommia ulmoides leaf extract, Populus davidiana Dode extract, Perilla frutescens leaf extract, Gynostemma pentaphyllum Makino extract, Leonurus japonicus extract and Astragalus membranaceus Bge extract) for sows in late pregnancy, and collects sow blood and placenta samples at the time of delivery, studies the influence of the composition on sow reproduction, and explores the mechanism of action. The experimental results show that the composition can improve the reproductive performance of sows by increasing the total number of piglets and other indicators; meanwhile, the composition can effectively inhibit the replication of PRRSv.
Owner:GUANGDONG OCEAN UNIVERSITY

Construction method and application of preeclampsia prediction model

PendingCN120048501AMedical data miningHealth-index calculationPhysiologyPlacenta Growth Factor
The invention develops a construction method of a novel preeclampsia prediction model based on insulin growth binding factor binding protein 1 (IGFBP1) and placental growth factor (PlGF) and related application of the novel preeclampsia prediction model. Specifically, according to the method, IGFBP1 and / or PLGF of a pregnant woman, clinical information and MAP data serve as input, whether the pregnant woman suffers from preeclampsia or not serves as output, model construction is conducted through a machine learning method, and a preeclampsia prediction model is obtained. As effective detection can be carried out only by adopting one or two protein predictive markers without depending on the uterine artery pulsation index, the cost is low, and on the whole, clinical popularization is more convenient, the medical expenditure is reduced, the mom and infant outcome is effectively improved, and the method has important significance on reducing the mortality rate of pregnant and lying-in women and infants.
Owner:BGI GENOMICS CO LTD +1

A culture medium, a preparation method and a culture method for industrialized preparation of mesenchymal stem cells

PendingCN122278756ACytokineCell therapy
This invention discloses a culture medium, preparation method, and culture method for the industrial-scale preparation of mesenchymal stem cells, belonging to the field of cell therapy technology. The culture medium comprises a basal medium, cell growth factors, cell proliferation promoters, a vitamin mixture, a nucleoside mixture, and an amino acid mixture; wherein the cell growth factors are selected from one or more of TGF-β, bFGF, VEGF, PDGF, EGF, and IGF. Through the synergistic effect of the composite nutrient system, this invention significantly improves the proliferation rate and cell viability of mesenchymal stem cells, maintains stem cell stemness, trilineage differentiation ability, and secretion levels of key cytokines (VEGF, HGF, TGF-β, IL-10, etc.); it can be stably and continuously passaged up to the 15th generation without abnormal changes in genetic material. This culture medium contains no animal-derived components, has high batch-to-batch stability, and is cost-controllable, making it suitable for GMP-level large-scale industrial preparation of mesenchymal stem cells from various sources such as umbilical cord, bone marrow, adipose tissue, and placenta.
Owner:JILIN TUO HUA BIOTECH